Similar articles

• Schizophrenia: a subcortical neurotransmitter imbalance syndrome?

  Carlsson M, Carlsson A. Carlsson M, et al. Schizophr Bull. 1990;16(3):425-32. doi: 10.1093/schbul/16.3.425. Schizophr Bull. 1990. PMID: 1981107 Review.
• Neurobiology of dopamine in schizophrenia.

  Guillin O, Abi-Dargham A, Laruelle M. Guillin O, et al. Int Rev Neurobiol. 2007;78:1-39. doi: 10.1016/S0074-7742(06)78001-1. Int Rev Neurobiol. 2007. PMID: 17349856 Review.
• Involvement of dopaminergic, cholinergic, and glutamatergic mechanisms in the actions of phencyclidine-like drugs.

  Johnson KM, Snell LD. Johnson KM, et al. NIDA Res Monogr. 1986;64:52-66. NIDA Res Monogr. 1986. PMID: 3086740 No abstract available.
• [Tremor and motility following oxotremorine and harmine in rats with lesions of the nigro-striatal system].

  Westermann KH, Oelszner W, Staib AH, Funk K. Westermann KH, et al. Acta Biol Med Ger. 1974;33(1):67-76. Acta Biol Med Ger. 1974. PMID: 4153886 German. No abstract available.
• [A biochemical theory of schizophrenia].

  Kornhuber HH, Kornhuber J, Kim JS, Kornhuber ME. Kornhuber HH, et al. Nervenarzt. 1984 Nov;55(11):602-6. Nervenarzt. 1984. PMID: 6151120 German.